相关实验视频

Updated: Jun 29, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

针对个性化抗癌疫苗的新抗原预测背后的方法

Kiyana Godazandeh¹, Lies Van Olmen¹, Lore Van Oudenhove¹

¹myNEO, Ghent, Belgium.

Methods in cell biology

|March 28, 2024

概括

本指南详细介绍了针对个性化癌症免疫治疗的内新抗原预测. 它概述了识别免疫原性新抗原的步骤和工具,从而提高治疗效率.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
免疫学免疫学免疫学

背景情况:

免疫疗法,包括免疫检查点抑制剂,已经显著推进了癌症治疗.
下一代测序和生物信息学使得患者特异性免疫原性新抗原的识别成为可能.
新抗原是开发个性化免疫疗法的关键标,可以更好地向癌细胞.

研究的目的:

提供一个全面的,一步一步的协议,用于在中新抗原预测.
讨论识别免疫原性新抗原所涉及的分析方法和挑战.
引导研究人员利用生物信息学工具进行新抗原发现.

主要方法:

利用下一代测序数据用于新抗原识别.
应用生物信息学管道用于变异调用和突变注释.
采用算法来预测新抗原结合亲和力和免疫性.
整合各种计算工具,实现完整的新抗原预测工作流程.

主要成果:

详细介绍了用于in-silico新抗原预测的详细协议.
突出了关键的分析步骤和潜在的挑战.
这项研究有助于识别用于免疫治疗的患者特异性新抗原.

结论:

在基中预测新抗原是个性化癌症免疫治疗的重要组成部分.
该协议提供了一种标准化的方法来识别新抗原.
准确的新抗原预测可以导致更有效和更有针对性的癌症治疗.

关键词:

生物信息学是一种生物信息学.新抗原检测检测新抗原检测个性化癌症免疫疗法个性化癌症免疫疗法

更多相关视频

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Vaccinations

Vaccinations